Hongming Chen

Executive Vice President, Research at Kala Pharmaceuticals, Inc.

Hongming Chen

Hongming Chen

Executive Vice President, Research at Kala Pharmaceuticals, Inc.

Overview
RelSci Relationships

59

Birthday

1972

Age

48

Contact Data
Trying to get in touch with Hongming Chen? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Hongming Chen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Accounting Officer, Chief Financial Officer & Treasurer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer at Visterra, Inc.

Relationship likelihood: Average

Entrepreneur in Residence at Omega Fund Management LLC

Relationship likelihood: Average

Executive Director, Account Management at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Executive Director, Trade & Alternate Channels at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Operating Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Paths to Hongming Chen
Potential Connections via
Relationship Science
You
Hongming Chen
Executive Vice President, Research at Kala Pharmaceuticals, Inc.
Education
BS Chemical Engineering
Class of 1992
Career History
Executive Vice President, Research
2010 - Current

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.

Director-Formulation Development
2000 - 2010

TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA.

Scientist
1997 - 2000

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Transactions
Details Hidden

Kala Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Kala Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Kala Pharmaceuticals, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hongming Chen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hongming Chen's profile does not indicate a business or promotional relationship of any kind between RelSci and Hongming Chen.